March 9, 2014
Notes: Alsafi, A
Hamady, M S
J Postgrad Med. 2013 Jan-Mar;59(1):69-75. doi: 10.4103/0022-3859.109509.
Author Address: Department of Interventional Radiology, Imperial College, St. Mary’s Hospital, Praed Street, London W2 1NY, United Kingdom.
Reference Type: Journal Article
Record Number: 531Author: Alzueta, J. and Fernandez, J. M.
Title: Spanish Implantable Cardioverter-defibrillator Registry. Ninth Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012)
Journal: Rev Esp Cardiol
Short Title: Spanish Implantable Cardioverter-defibrillator Registry. Ninth Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012)
Alternate Journal: Revista espanola de cardiologia
ISSN: 1579-2242 (Electronic)
Original Publication: Registro Espanol de Desfibrilador Automatico Implantable. IX Informe Oficial de la Seccion de Electrofisiologia y Arritmias de la Sociedad Espanola de Cardiologia (2012).
Accession Number: 24063772
Abstract: INTRODUCTION AND OBJECTIVES: To summarize the findings of the Spanish Implantable Cardioverter-defibrillator Registry for 2012 compiled by the Electrophysiology and Arrhythmias Section of the Spanish Society of Cardiology. METHODS: Prospective data recorded voluntarily on single-page questionnaires were sent to the Spanish Society of Cardiology by each implantation team. RESULTS: Overall, 4216 device implantations were reported, representing 80.8% of the estimated total number of implantations. The reported implantation rate was 91.2 per million population and the estimated total implantation rate was 113 per million. The proportion of first implantations was 69.4%. We collected data from 161 hospitals (6 fewer than in 2011). The majority of implantable cardioverter-defibrillator recipients were men (83.4%). Mean age was 61.8 (13.4) years. Most patients had severe or moderate-to-severe ventricular dysfunction and were in New York Heart Association functional class II. Ischemic heart disease was the most frequent underlying cardiac condition, followed by dilated cardiomyopathy. The number of indications for primary prevention decreased over the previous year and now account for 58.1% of first implantations. Overall, 81% of the implantable cardioverter-defibrillator were implanted by cardiac electrophysiologists. CONCLUSIONS: The 2012 Spanish Implantable Cardioverter-defibrillator Registry includes data on 80.8% of all implantable cardioverter-defibrillators implantations performed in Spain. This is the second consecutive year in which the number of implantations has slightly decreased compared to the previous year. This year, the percentage of implantations for primary prevention indications also decreased. Full English text available from:www.revespcardiol.org/en.